Muscle Wasting Disorders Market Expansion Outlook: $29.52 Billion by 2029 Forecast

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Muscle Wasting Disorders Market Between 2025 And 2029?

The muscle wasting disorders market size has experienced rapid growth over recent years. It is projected to expand from $15.06 billion in 2024 to $17.49 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.1%. This historic growth can be ascribed to several factors, including an increasing aging population, a rising incidence of chronic diseases, advancements in research and development, increased awareness promoting early diagnosis, and the development of emerging therapeutic approaches.

The muscle wasting disorders market is anticipated to show substantial growth over the next few years. It is projected to expand to $29.52 billion by 2029, achieving a compound annual growth rate (CAGR) of 14.0%. The expansion during this forecast period is primarily driven by strong regulatory backing, a rise in patient advocacy efforts, improvements in healthcare infrastructure, the worldwide reach of clinical trials, and the adoption of personalized medicine strategies. Significant developments expected in the forecast period include the increased use of telemedicine, continuous technological advancements in diagnostics, ongoing product innovation, formation of collaborations and partnerships, breakthroughs in therapeutic interventions, intensified research into molecular mechanisms, and further biopharmaceutical innovation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp

Which Drivers Are Supporting Growth Of The Muscle Wasting Disorders Market?

The increasing adoption of a sedentary lifestyle is projected to stimulate the growth of the muscle wasting disorders market moving forward. A sedentary lifestyle describes a way of living where an individual is physically inactive, undertaking minimal or no physical movement or exercise. This type of behavior can adversely affect muscle function, leading to diminished muscle strength and endurance, thereby contributing to muscle wasting disorders and making it more challenging for individuals to preserve their muscle mass and function. For example, in 2022, the World Health Organization, a Switzerland-based intergovernmental organization, reported that over 80% of adolescents and 27% of adults did not adhere to their recommended physical activity levels. Consequently, the rising adherence to a sedentary lifestyle is a significant driver for the expansion of the muscle wasting disorders market.

What Are The Different Segment Classifications Within The Muscle Wasting Disorders Market?

The muscle wasting disordersmarket covered in this report is segmented –

1) By Treatment Type: Medications; Physical Therapy; Nutritional Therapy; Surgery; Gene Therapy; Other Treatment Types

2) By Disorder Type: Muscular Dystrophy; Amyotrophic Lateral Sclerosis (ALS); Other Disorder Types

3) By End-User: Hospitals; Rehab Centers; Specialty Clinics; Other End-Users

Subsegments:

1) By Medications: Anabolic Steroids; Hormonal Treatments; Anti-Inflammatory Drugs; Immunomodulatory Agents

2) By Physical Therapy: Resistance Training; Stretching Exercises; Aerobic Conditioning; Rehabilitation Programs

3) By Nutritional Therapy: Protein Supplements; Nutritional Counseling; Dietary Modifications; Micronutrient Supplements

4) By Surgery: Surgical Interventions For Muscle Repair; Orthopedic Surgeries; Procedures For Underlying Conditions

5) By Gene Therapy: Gene Replacement Therapy; CRISPR-Based Approaches; RNA Interference Techniques

6) By Other Treatment Types: Complementary Therapies; Psychological Support; Assistive Devices

Which Competitive Trends Are Defining The Muscle Wasting Disorders Market Structure?

Leading companies active in the muscle wasting disorders market are developing innovative products, such as novel gene therapy, to better serve patients afflicted with muscle wasting disorders. Novel gene therapy denotes a medical technology designed to achieve a therapeutic effect by manipulating gene expression or altering the biological properties of living cells. For example, in June 2023, Sarepta Therapeutics, a US-based biotechnology company, unveiled Elevidys, which marks the first gene therapy approved by the U.S. Food and Drug Administration (FDA) for treating Duchenne muscular dystrophy (DMD) in pediatric patients between the ages of 4 and 5 years old. Elevidys is a recombinant gene therapy specifically engineered to deliver a gene into the body that results in a shortened protein containing selected domains of the dystrophin protein found in normal muscle cells. The product is administered as a single intravenous infusion.

Which Major Firms Are Strengthening Their Position In The Muscle Wasting Disorders Industry?

Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

How Do Regional Market Performances Compare Within The Muscle Wasting Disorders Industry?

North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Muscle Wasting Disorders Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13706&type=smp

Browse Through More Reports Similar to the Global Muscle Wasting Disorders Market 2025, By The Business Research Company

Anorectal Disorders Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report

Optic Nerve Disorders Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Bleeding Disorders Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795